The economic impact of drug use on the workforce is being felt across the country, and perhaps nowhere more than in the Youngstown, Ohio, region, which is struggling to overcome decades of deindustrialization.
YOUNGSTOWN, Ohio — Just a few miles from where President Donald Trump addressed his blue-collar base here this month, the kind of middle-class factory jobs he has vowed to bring back from overseas are going begging.
It’s not that local workers lack the skills for these positions, many of which do not even require a high-school diploma but pay $15 to $25 an hour and offer full benefits. Rather, the problem is that too many applicants — nearly half, in some cases — fail a drug test.
The fallout is not limited to the workers or their immediate families. Each quarter, Columbiana Boiler, a local company, forgoes roughly $200,000 worth of orders for its galvanized containers and kettles because of the manpower shortage, it says, with foreign rivals picking up the slack.
“Our main competitor in Germany can get things done more quickly because they have a better labor pool,” said Michael J. Sherwin, chief executive of the 123-year-old manufacturer. “We are always looking for people and have standard ads at all times, but at least 25 percent fail the drug tests.”
Most Read Stories
The economic impact of drug use on the workforce is being felt across the country, and perhaps nowhere more than in this region, which is struggling to overcome decades of deindustrialization.
Indeed, the opioid epidemic and, to some extent, wider marijuana use are hitting businesses and the economy in ways that are beginning to be acknowledged by policymakers and other experts.
A federal study estimated that prescription opioid abuse cost the economy $78.5 billion in 2013, but that does not capture the broader effect on businesses from factors like lost productivity, according to Curtis S. Florence, who led the research for the National Center for Injury Prevention and Control.
“That’s definitely a conservative estimate,” Florence said. “It’s very hard to measure how it affects employers, but if we could, it would be in addition to what we see here.”
The effect is seen not just in the applicants eliminated based on drug screening, but in those deterred from even applying. In congressional testimony this month, the Federal Reserve chair, Janet Yellen, linked increased…